(Date:1/8/2009)...been one of the most amazing recovery cases I have...el Kronenberger, MD, Otolaryngology, Dallas, TX ,...an of four years, Wally Hogland suffered a stroke,...nced stage IV cancer. , , "When my doctor came ...ears welling up in his eyes at the painful recolle...
(Date:1/8/2009)... patients living in poorer areas of B.C. are up to... patients living in better-off areas, a University...arch, released this week in the online journal Pu...y disease patients living in lower socioeconomic n...ronic disease, particularly cancer. , "Even in a...
(Date:1/8/2009)... Researchers at Oregon Health & Science Universit...discovered that the nerve cells controlling heart ...n to be critically important for proper nervous sy...ificant role in the prevention of Sudden Infant De...ding to the National Institutes of Health, SIDS is...
(Date:1/8/2009)...alif., Jan. 8 VNUS Medic... provider of medical devices for the minimally inv...nounced its plans to present at the 27th Annual J....y 12 - 15, 2009, at the Westin St. Francis Hotel i...rian Farley, President and Chief Executive Officer...
Breaking Medicine News(10 mins):Health News:One Man's Determined Journey to Remission and a Renewed Sense of Faith 2Health News:Mortality rates higher for heart disease patients in poorer B.C. neighborhoods 2Health News:OHSU School of Dentistry team discovers new molecule in blood-pressure control system 2...sts children undergoing liver transplants may fare...nce organ transplants began, steroids have played ...ion of their new organ. However, the treatment is ...n children. Steroids have been linked to infection...
...st is a convenient and relatively inexpensive way ...cacy of PSA is controversial in younger men, docto...//should not be given to men over 75. Despite this...suggesting and doing a PSA test on older men. The ...
...izumab may reduce symptoms of psoriasis and improv...oyola University studied more than 550 patients wh...ns of efalizumab (Raptiva) or a placebo for three ...nt of each patient’s condition and rated the degre...
...betes have a higher risk of depression. British re...es 60 and 79. The participants were divided //into...iabetes, and the second included those without dia...e again divided into four smaller groups, based on...
Other Medicine News:(Date:1/6/2009)...ass., Jan. 6 Cequent Pharmaceutica... to deliver RNAi-based treatments to prevent and t... recently completed a successful toxicology study ...k RNAi therapeutic targeting the primary oncogene ...s polyposis). FAP is an inherited gastrointestinal...
(Date:1/5/2009)..., Md., Jan. 5 Micromet, ...ny developing novel, proprietary,antibodies for t...e diseases,provides an outlook on key events ant...tends to provide an update on its research and dev... -- April 12 to 16, 2009: Update on several prec...
(Date:12/29/2008)...., Dec. 29 The winner o...Protection was announced today by Dr. Peter G. Gol...ovement Institute. , , The winner of the annua...son Cancer Center -- for its best practice " IND... provides for 1) enhanced human subjects protectio...
(Date:12/17/2008)...stone met in development and validation of non-ani...ass., Dec. 17 MatTek Corporation t...Committee (ESAC) endorsed the scientific validity ... at its November meeting. ESAC concluded that the...reliability for the prediction of skin irritating ...
Breaking Medicine Technology:Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 52008 Human Research Protection Award Recipients Announced 2EpiDerm's Skin Irritation Test Fully Validated in European Union 2Candidate Experiences Life in Homecare Workers Shoes 13609 1Candidate Experiences Life in Homecare Workers Shoes 13609 2Ventas Appoints James D Shelton and Robert D Reed to Board 13607 1Ventas Appoints James D Shelton and Robert D Reed to Board 13607 2Ventas Appoints James D Shelton and Robert D Reed to Board 13607 3Ventas Appoints James D Shelton and Robert D Reed to Board 13607 4Ventas Appoints James D Shelton and Robert D Reed to Board 13607 5Home Oxygen Community Applauds Senator Ken Salazar for Joining Bi Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit 13603 1Home Oxygen Community Applauds Senator Ken Salazar for Joining Bi Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit 13603 2Home Oxygen Community Applauds Senator Ken Salazar for Joining Bi Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit 13603 3Home Oxygen Community Applauds Senator Ken Salazar for Joining Bi Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit 13603 4Home Oxygen Community Applauds Senator Ken Salazar for Joining Bi Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit 13603 5Home Oxygen Community Applauds Senator Ken Salazar for Joining Bi Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit 13603 6ACR Supports American Cancer Society Inclusion of CT Colonography 28Virtual Colonoscopy 29 as Recommended Screening Tool for Colorectal Cancer in New 1470 1ACR Supports American Cancer Society Inclusion of CT Colonography 28Virtual Colonoscopy 29 as Recommended Screening Tool for Colorectal Cancer in New 1470 2ACR Supports American Cancer Society Inclusion of CT Colonography 28Virtual Colonoscopy 29 as Recommended Screening Tool for Colorectal Cancer in New 1470 3...y evaluating a clinically relevant model of,normal...t capable,of abrogating the cytotoxic effect of er...PTISOME(tm) agent was generally well,tolerated in ...,profile similar to conventional vincristine , SOU...WIRE) --,Hana Biosciences (Nasdaq:HNAB), a biophar...
...WIRE)--Jun 4, 2007 - Introgen Therapeutics, Inc.,(...tors today,reported updated Phase 2 data demonstra...3, tumor responses and increased,survival followin...uamous cell carcinoma of the head and neck. The da...nual meeting of the American,Society of Clinical O...
Other Medicine Technology:Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 2Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 3Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 4Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 5Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 2Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 3Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 4...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: